Journal
NATURE BIOMEDICAL ENGINEERING
Volume 4, Issue 7, Pages 670-671Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41551-020-0586-x
Keywords
-
Categories
Ask authors/readers for more resources
The partial depletion of red blood cells via the administration of a low dose of anti-erythrocyte antibodies increases the circulation half-life of nanomedicines, as shown in rodent models of cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
